1. Home
  2. EHTH vs VNDA Comparison

EHTH vs VNDA Comparison

Compare EHTH & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHTH
  • VNDA
  • Stock Information
  • Founded
  • EHTH 1997
  • VNDA 2002
  • Country
  • EHTH United States
  • VNDA United States
  • Employees
  • EHTH N/A
  • VNDA N/A
  • Industry
  • EHTH Specialty Insurers
  • VNDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EHTH Finance
  • VNDA Health Care
  • Exchange
  • EHTH Nasdaq
  • VNDA Nasdaq
  • Market Cap
  • EHTH 125.6M
  • VNDA 288.2M
  • IPO Year
  • EHTH 2006
  • VNDA 2006
  • Fundamental
  • Price
  • EHTH $3.89
  • VNDA $4.78
  • Analyst Decision
  • EHTH Hold
  • VNDA Strong Buy
  • Analyst Count
  • EHTH 5
  • VNDA 3
  • Target Price
  • EHTH $7.60
  • VNDA $15.33
  • AVG Volume (30 Days)
  • EHTH 450.2K
  • VNDA 421.0K
  • Earning Date
  • EHTH 08-06-2025
  • VNDA 07-30-2025
  • Dividend Yield
  • EHTH N/A
  • VNDA N/A
  • EPS Growth
  • EHTH N/A
  • VNDA N/A
  • EPS
  • EHTH N/A
  • VNDA N/A
  • Revenue
  • EHTH $552,565,000.00
  • VNDA $201,351,000.00
  • Revenue This Year
  • EHTH $1.84
  • VNDA $16.86
  • Revenue Next Year
  • EHTH $6.72
  • VNDA $39.78
  • P/E Ratio
  • EHTH N/A
  • VNDA N/A
  • Revenue Growth
  • EHTH 17.04
  • VNDA 13.37
  • 52 Week Low
  • EHTH $3.58
  • VNDA $3.81
  • 52 Week High
  • EHTH $11.36
  • VNDA $6.37
  • Technical
  • Relative Strength Index (RSI)
  • EHTH 37.03
  • VNDA 53.88
  • Support Level
  • EHTH $4.10
  • VNDA $4.85
  • Resistance Level
  • EHTH $4.31
  • VNDA $5.12
  • Average True Range (ATR)
  • EHTH 0.20
  • VNDA 0.18
  • MACD
  • EHTH 0.01
  • VNDA 0.01
  • Stochastic Oscillator
  • EHTH 7.02
  • VNDA 54.05

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: